Although SCLC-I tumors were recognized as ‘triple-negative’ SCLCs without ASCL1, NEUROD1, and POU2F3 expression, these tumors have also been proposed to be additional subtypes that express different transcription factors such as ATOH1 [52]. The gene discussed is ATOH1; the disease is small cell lung carcinoma.